Bicara Therapeutics To Rally Around 121%? Here Are 10 Top Analyst Forecasts For Tuesday

Abbott Laboratories -0.46% Post
Bicara Therapeutics Inc. +2.11% Post
BTCS -4.64% Post
Corpay, Inc. -0.63% Post
nCino +3.80% Post

Abbott Laboratories

ABT

101.83

101.83

-0.46%

0.00% Post

Bicara Therapeutics Inc.

BCAX

21.29

21.29

+2.11%

0.00% Post

BTCS

BTCS

1.44

1.44

-4.64%

0.00% Post

Corpay, Inc.

CPAY

296.35

296.35

-0.63%

0.00% Post

nCino

NCNO

18.02

18.05

+3.80%

+0.17% Post

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • BTIG cut the price target for Abbott Laboratories (NYSE:ABT) from $140 to $131. BTIG analyst Marie Thibault maintained a Buy rating. Abbott shares closed at $101.88 on Monday. See how other analysts view this stock.
  • HC Wainwright & Co. cut BTCS Inc. (NASDAQ:BTCS) price target from $7 to $5. HC Wainwright & Co. analyst Kevin Dede maintained a Buy rating. BTCS shares closed at $1.29 on Monday. See how other analysts view this stock.
  • Needham slashed price target for Phreesia, Inc. (NYSE:PHR) from $35 to $14. Needham analyst Ryan MacDonald maintained a Buy rating. Phreesia shares closed at $11.41 on Monday. See how other analysts view this stock.
  • HC Wainwright & Co. raised the price target for Bicara Therapeutics Inc. (NASDAQ:BCAX) from $40 to $42. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Bicara Therapeutics shares closed at $19.04 on Monday. See how other analysts view this stock.
  • Baird cut nCino, Inc. (NASDAQ:NCNO) price target from $34 to $24. Baird analyst Joe Vruwink maintained an Outperform rating. nCino shares closed at $14.42 on Monday. See how other analysts view this stock.
  • B of A Securities raised Shake Shack Inc. (NASDAQ:SHAK) price target from $88 to $101. B of A Securities analyst Sara Senatore upgraded the stock from Underperform to Neutral. Shake Shack shares closed at $83.53 on Monday. See how other analysts view this stock.
  • Baird cut Corpay, Inc. (NYSE:CPAY) price target from $440 to $380. Baird analyst David Koning maintained an Outperform rating. Corpay shares closed at $290.36 on Monday. See how other analysts view this stock.
  • BMO Capital cut the price target for Phreesia, Inc. (NYSE:PHR) from $32 to $14. BMO Capital analyst Sean Dodge maintained an Outperform rating. Phreesia shares closed at $11.41 on Monday. See how other analysts view this stock.
  • HC Wainwright & Co. cut Viridian Therapeutics, Inc. (NASDAQ:VRDN) price target from $34 to $22. HC Wainwright & Co. analyst Douglas Tsao maintained a Buy rating. Viridian Therapeutics shares closed at $18.53 on Monday. See how other analysts view this stock.
  • Canaccord Genuity cut USA Rare Earth, Inc. (NASDAQ:USAR) price target from $33 to $29. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. USA Rare Earth shares closed at $14.23 on Monday. See how other analysts view this stock.

Considering buying BCAX stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.